MetaCap

Aveanna Healthcare Holdings Inc. (AVAH)

NASDAQ: AVAHHealth CareMedical/Nursing ServicesUSD

11.01+0.31 (+2.90%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AVAH stock chart

Technical analysis

Key statistics

All statistics
52-week range
5.93 – 14.71
Day range
10.65 – 11.03
Volume / Avg
2.17M / 2.77M
Beta
—

52-week range

$5.93$14.71

AVAH stock today

Aveanna Healthcare (AVAH) closed at $11.01 on Nov 20, up 2.90% (+$0.31), versus the S&P 500's 3.70% decline. At this level, AVAH sits in the middle of its 52-week range of $5.93 to $14.71: 25.2% below the high, set on Sep 16, 2026 and 85.7% above the low. AVAH is up 34.8% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 26.0%.

At 7.9x trailing earnings, Aveanna Healthcare trades below the peer-group median of 65.3x. Its forward P/E of 12.1x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Aveanna Healthcare

Company profile

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS).

Industry
Medical/Nursing Services
CEO
Mr. Jeffrey S. Shaner
Headquarters
Atlanta, GA
Employees
3,500
IPO year
2021

Financial highlights

Full financials

In fiscal 2026, Aveanna Healthcare generated $2.43 billion in revenue, up 20.2% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $225.0 million, for a net margin of 9.2% versus a median of -7.0% in the prior 5 years. Gross margin was 33.3% (up from 31.4%) and operating margin 10.5%.

Aveanna Healthcare annual revenue, net income and EPS
Fiscal yearFY 2026FY 2024FY 2023FY 2022FY 2022
Revenue$2.43B$2.02B$1.90B$1.79B$1.68B
Growth+20.19%+6.82%+6.02%+6.50%+12.27%
Net income$225.03M$-10.93M$-134.52M$-662.03M$-117.04M
EPS (diluted)$1.05$-0.06$-0.71$-3.57$-0.69

Analyst forecast

Forecast

Consensus (11 analysts)

buy

Avg. price target

$15.20+38.06%

  • Strong buy 2
  • Buy 6
  • Hold 3
  • Sell 0
  • Strong sell 0

Target range

Low $13.00High $16.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$0.22 vs $0.19
Surprise
+15.79%

AVAH news

All AVAH news

Aveanna Healthcare peers

Health Care sector
AVAH peer companies
CompanyPrice% ChgMarket capCompare
ADUSAddus HomeCare Corporation122.50+1.18%$2.28Bvs AVAH
PRVAPrivia Health Group Inc.25.05+1.46%$3.20Bvs AVAH
USPHU.S. Physical Therapy Inc.95.93+1.71%$1.43Bvs AVAH
HIMSHims & Hers Health Inc. Class A14.60-8.86%$3.42Bvs AVAH
WGSGeneDx Holdings Corp. Class A45.46-7.68%$1.36Bvs AVAH
TDOCTeladoc Health Inc.7.45-4.36%$1.36Bvs AVAH
INNVInnovAge Holding Corp.9.16+2.81%$1.25Bvs AVAH
PNTGThe Pennant Group Inc.34.64+1.61%$1.22Bvs AVAH

Indexes, lists and sector

Aveanna Healthcare stock FAQ

What is Aveanna Healthcare's stock price today?

AVAH last traded at $11.01 as of Nov 20, 4:00 PM EST, up 2.90% on the day. Prices are delayed at least 15 minutes.

What is AVAH's P/E ratio?

AVAH trades at a trailing P/E ratio of 7.86 and a forward P/E of 12.09, compared with a median of 65.3 for its closest peers.

Who is Aveanna Healthcare's CEO?

Mr. Jeffrey S. Shaner is the chief executive officer of Aveanna Healthcare Holdings Inc., which has about 3,500 employees.

What is the AVAH 52-week high?

The 52-week high for AVAH is $14.71 and the 52-week low is $5.93. The stock is currently 25.2% below its high.

Compare AVAH